Healthcare

Medial EarlySign Reaches Milestone of 30 Validated Studies Published in Leading Journals and Scientific Poster Sessions

British Medical Journal Open Gastroenterology Publishes NHS Study Indicating ColonFlag™ Assists Detection of Colorectal Cancer TEL AVIV, Israel, Dec. 19, 2024…

1 day ago

Darmiyan Enters Medicare GUIDE Program Through Partnership with Five Star Home Health Care, CareBrains, and Brain Watch Coalition

SAN FRANCISCO, Dec. 19, 2024 /PRNewswire/ -- Darmiyan, Inc., a leader in brain health technology, proudly announces its participation in…

1 day ago

Provident Healthcare Partners Advises Mid-Florida Endodontics on its Partnership with SRM Equity Partners

BOSTON and NEW YORK, Dec. 19, 2024 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced…

1 day ago

Caris Life Sciences Exceeds 1,000 Published Studies Milestone

IRVING, Texas, Dec. 19, 2024 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer,…

1 day ago

Black Book Market Research Releases Global Survey Findings on Population Health Applications in Emerging Markets

LONDON, UNITED KINGDOM / ACCESSWIRE / December 19, 2024 / Black Book Market Research, a leading global healthcare technology research…

1 day ago

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer

Seasoned executive brings a broad skill set to Zomedica's leadership team ANN ARBOR, MI / ACCESSWIRE / December 19, 2024…

1 day ago

KFSHRC Inaugurates MENA’s Most Advanced Hematology Diagnostics Laboratory

RIYADH, Saudia Arabia, Dec. 19, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) inaugurated the Advanced…

1 day ago

Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends

FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025 Gimoti remains only approved…

1 day ago

YORVIPATH® (Palopegteriparatide) Now Commercially Available in the United States for the Treatment of Hypoparathyroidism in Adults

COPENHAGEN, Denmark, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that YORVIPATH® (palopegteriparatide; developed as…

1 day ago